Max Healthcare Institute Limited (BOM:543220)
India
· Delayed Price · Currency is INR 1,040.60
-2.10 (-0.20%)
At close: Mar 9, 2026
Max Healthcare Institute Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,012,600 | 1,066,148 | 797,357 | 428,177 | 336,359 | 199,033 | Upgrade
|
| Market Cap Growth | 3.66% | 33.71% | 86.22% | 27.30% | 69.00% | - | Upgrade
|
| Enterprise Value | 1,040,380 | 1,070,967 | 786,040 | 427,502 | 339,102 | 212,818 | Upgrade
|
| Last Close Price | 1040.60 | 1095.44 | 818.04 | 439.00 | 345.33 | 205.12 | Upgrade
|
| PE Ratio | 71.61 | 99.10 | 75.39 | 38.80 | 55.59 | - | Upgrade
|
| Forward PE | 54.58 | 60.58 | 53.35 | 36.97 | 36.67 | - | Upgrade
|
| PS Ratio | 12.44 | 15.17 | 14.75 | 9.38 | 8.55 | 7.94 | Upgrade
|
| PB Ratio | 10.07 | 11.37 | 9.48 | 5.78 | 5.35 | 3.53 | Upgrade
|
| P/TBV Ratio | 25.13 | 31.87 | 28.22 | 18.27 | 28.70 | 23.41 | Upgrade
|
| P/FCF Ratio | - | 215.92 | 237.51 | 45.14 | 179.70 | - | Upgrade
|
| P/OCF Ratio | - | 73.06 | 71.09 | 33.34 | 45.42 | 168.87 | Upgrade
|
| PEG Ratio | 2.64 | 2.58 | 3.47 | 2.47 | 0.59 | - | Upgrade
|
| EV/Sales Ratio | 12.78 | 15.24 | 14.54 | 9.37 | 8.61 | 8.49 | Upgrade
|
| EV/EBITDA Ratio | 47.58 | 58.49 | 53.04 | 34.97 | 35.83 | 54.63 | Upgrade
|
| EV/EBIT Ratio | 59.05 | 70.11 | 61.64 | 41.75 | 44.74 | 87.56 | Upgrade
|
| EV/FCF Ratio | - | 216.89 | 234.14 | 45.07 | 181.16 | - | Upgrade
|
| Debt / Equity Ratio | 0.33 | 0.32 | 0.15 | 0.09 | 0.14 | 0.20 | Upgrade
|
| Debt / EBITDA Ratio | 1.50 | 1.60 | 0.86 | 0.55 | 0.94 | 2.69 | Upgrade
|
| Debt / FCF Ratio | - | 6.10 | 3.87 | 0.73 | 4.88 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.28 | 0.25 | 0.04 | -0.09 | 0.07 | 0.08 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.30 | 1.28 | 0.22 | -0.56 | 0.46 | 1.22 | Upgrade
|
| Net Debt / FCF Ratio | - | 4.76 | 0.95 | -0.72 | 2.31 | -847.54 | Upgrade
|
| Asset Turnover | - | 0.52 | 0.49 | 0.47 | 0.44 | 0.40 | Upgrade
|
| Inventory Turnover | - | 28.50 | 26.31 | 25.17 | 30.36 | 30.58 | Upgrade
|
| Quick Ratio | - | 0.78 | 1.19 | 1.67 | 1.18 | 1.31 | Upgrade
|
| Current Ratio | - | 0.88 | 1.37 | 1.86 | 1.32 | 1.45 | Upgrade
|
| Return on Equity (ROE) | - | 12.10% | 13.37% | 16.12% | 10.15% | -3.36% | Upgrade
|
| Return on Assets (ROA) | - | 7.02% | 7.21% | 6.64% | 5.34% | 2.43% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.08% | 11.43% | 12.79% | 15.24% | 9.68% | 6.71% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 11.40% | 11.90% | 11.30% | 9.00% | 3.10% | Upgrade
|
| Earnings Yield | 1.40% | 1.01% | 1.33% | 2.58% | 1.80% | -0.69% | Upgrade
|
| FCF Yield | - | 0.46% | 0.42% | 2.21% | 0.56% | -0.00% | Upgrade
|
| Dividend Yield | 0.14% | 0.14% | 0.18% | 0.23% | - | - | Upgrade
|
| Payout Ratio | - | 13.53% | 9.17% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | 0.10% | -0.20% | -0.39% | -0.24% | -12.30% | -47.77% | Upgrade
|
| Total Shareholder Return | 0.25% | -0.07% | -0.20% | -0.01% | -12.30% | -47.77% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.